Monashee Investment Management is a hedge fund.
Monashee Investment Management is a hedge fund.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 27, 2021
Skyryse
|
Series B | $200M | Aerospace | Yes |
|
Jun 25, 2021
Kindbody
|
Series C | $62M | Employee Benefits | — |
|
Mar 19, 2021
X4 Pharmaceuticals
|
Post-IPO Equity | $55M | Biotechnology | — |
|
Nov 25, 2020
SomaLogic
|
Series A | $121M | Biotechnology | — |